PRA Collaborates on Vaccine Studies

PRA Health Sciences (PRA) announced a collaboration with the Alliance for Multispecialty Research (AMR) to improve the efficiency of vaccine studies. AMR is a network of independently owned, geographically diverse, and experienced Clinical Research Centers of Excellence and along with PRA’s vaccine experience in Phase I-IV trials will facilitate identification of appropriate vaccine study populations, as well as address subject retention and trial conduct in this area.